Print

AstraZeneca PLC (AZN) Heart Drug Faces Hurdles in Tough EU Market  
4/6/2011 7:22:18 AM

LONDON, April 6 (Reuters) - AstraZeneca's (AZN.L) big new drug hope Brilinta faces an uphill fight in Europe as its maker negotiates a series of hurdles that underscore the tough pharmaceutical landscape across the continent.
//-->